AnalystsSwayampakula RamakanthSwayampakula Ramakanth's Stock Forecasts
AnalystsSwayampakula Ramakanth
Analyst Ranking
Top 3%
#139 out of 5272 analysts
Average Return
+10.71%
Win Rate
41%251 out of 614
Risk vs Reward
Poor
Good
Swayampakula Ramakanth's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celcuity IncCELC | +892.79% | $9.29 | $92.23 | 2025-04-01 - 2025-11-17 | Buy |
Celcuity IncCELC | +762.77% | $10.69 | $92.23 | 2025-05-19 - 2025-11-17 | Buy |
Janux Therapeutics IncJANX | +645.28% | $7.09 | $52.84 | 2023-11-13 - 2024-11-12 | Buy |
Celcuity IncCELC | +632.07% | $12.66 | $92.68 | 2024-11-15 - 2025-11-14 | Buy |
Immunogen IncIMGN | +559.55% | $4.45 | $29.35 | 2023-03-02 - 2023-11-30 | Buy |
Swayampakula Ramakanth Analyst Color
Get additional color on Swayampakula Ramakanth's coverage of popular stocks
Swayampakula Ramakanth's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 8 | Buy | $175.00 | +63.31% | Maintains | 7 days ago |
Celcuity IncCELC | 12 | Buy | $165.00 | +25.90% | Upgrades | 7 days ago |
Corcept Therapeutics IncCORT | 29 | Buy | $75.00 | +43.46% | Maintains | 7 days ago |
Evaxion AEVAX | 16 | Buy | $16.00 | +268.66% | Reiterates | 17 days ago |
Actuate Therapeutics IncACTU | 6 | Buy | $15.00 | +354.55% | Reiterates | 19 days ago |
Nuvalent IncNUVL | 6 | Buy | $155.00 | +47.23% | Reiterates | 20 days ago |
Vor Biopharma IncVOR | 16 | Buy | $31.00 | +83.00% | Maintains | a month ago |
Edap Tms SaEDAP | 13 | Buy | $10.00 | +142.13% | Maintains | a month ago |
Renovorx IncRNXT | 4 | Buy | $3.00 | +247.22% | Reiterates | a month ago |
Innate Pharma SaIPHA | 17 | Buy | $5.00 | +254.61% | Reiterates | a month ago |
Precigen IncPGEN | 15 | Buy | $10.00 | +137.53% | Maintains | 2 months ago |
Ocugen IncOCGN | 21 | Buy | $10.00 | +562.25% | Maintains | 2 months ago |
Pyxis Oncology IncPYXS | 12 | Buy | $7.00 | +155.47% | Reiterates | 2 months ago |
Eton Pharmaceuticals IncETON | 10 | Buy | $52.00 | +75.38% | Maintains | 2 months ago |
Lifeward LtdLFWD | 18 | Buy | $10.00 | +58.73% | Maintains | 2 months ago |
In8bio IncINAB | 16 | Buy | $6.00 | +279.75% | Reiterates | 2 months ago |
Alx Oncology Holdings IncALXO | 16 | Buy | $4.00 | +92.31% | Reiterates | 2 months ago |
Dianthus Therapeutics IncDNTH | 9 | Buy | $130.00 | +49.93% | Maintains | 2 months ago |
Vericel CorpVCEL | 16 | Buy | $64.00 | +91.27% | Maintains | 2 months ago |
Electrocore IncECOR | 14 | Buy | $18.00 | +180.81% | Maintains | 4 months ago |
Delcath Systems IncDCTH | 16 | Buy | $30.00 | +161.32% | Reiterates | 4 months ago |
Compugen LtdCGEN | 1 | Buy | $4.00 | +37.93% | Initiates Coverage On | 4 months ago |
Absci CorpABSI | 15 | Buy | $8.00 | +35.59% | Maintains | 5 months ago |
Janux Therapeutics IncJANX | 14 | Buy | $45.00 | +217.46% | Maintains | 5 months ago |
Mediwound LtdMDWD | 19 | Buy | $36.00 | +117.26% | Maintains | 6 months ago |
Chronoscale CorpCHRN | 16 | Buy | $6.00 | -61.46% | Maintains | 6 months ago |
Personalis IncPSNL | 19 | Buy | $13.00 | +117.39% | Maintains | 6 months ago |
X4 Pharmaceuticals IncXFOR | 18 | Buy | $5.00 | +12.87% | Maintains | 6 months ago |
Can Fite Biopharma LtdCANF | 1 | Buy | $50.00 | +1,324.50% | Assumes | 6 months ago |
Unicycive Therapeutics IncUNCY | 2 | Buy | $22.00 | +177.08% | Maintains | 6 months ago |
Dyadic International IncDYAI | 1 | Buy | $3.00 | +289.61% | Assumes | 7 months ago |
Collplant Biotechnologies LtdCLGN | 10 | Buy | $11.00 | +2,636.32% | Reiterates | 9 months ago |
Aethlon Medical IncAEMD | 2 | Hold | $15.00 | +566.67% | Reiterates | 9 months ago |
Humacyte IncHUMA | 2 | Buy | $3.00 | +183.02% | Maintains | 9 months ago |
Elevation Oncology IncELEV | 9 | Hold | $0.36 | -1.37% | Downgrades | a year ago |
Mindwalk Holdings CorpHYFT | 11 | Buy | $5.00 | N/A | Reiterates | a year ago |
Spectral Ai IncMDAI | 4 | Buy | $3.50 | N/A | Reiterates | a year ago |
Iteos Therapeutics IncITOS | 11 | Buy | $46.00 | N/A | Reiterates | a year ago |
Bicycle Therapeutics PLCBCYC | 16 | Buy | $33.00 | N/A | Reiterates | a year ago |
Cypherpunk Technologies IncCYPH | 13 | Buy | $5.50 | N/A | Reiterates | a year ago |
Quantum Si IncQSI | 6 | Buy | $5.50 | N/A | Reiterates | a year ago |
Affimed NvAFMDQ | 12 | Buy | $10.00 | N/A | Reiterates | a year ago |
Intensity Therapeutics IncINTS | 2 | Buy | $125.00 | N/A | Reiterates | a year ago |
Cyclo Therapeutics IncCYTH | 4 | Hold | $0.95 | N/A | Downgrades | 2 years ago |
Axe Compute IncAGPU | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Asensus Surgical IncASXC | 11 | Hold | $0.35 | N/A | Reiterates | 2 years ago |
Mimedx Group IncMDXG | 8 | Buy | $11.00 | N/A | Reiterates | 2 years ago |
Calcimedica IncCALC | 1 | Buy | $20.00 | N/A | Reiterates | 2 years ago |
Avinger IncAVGR | 5 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Harpoon Therapeutics IncHARP | 8 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Solid Biosciences IncSLDB | 1 | Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Immunogen IncIMGN | 10 | Hold | $31.26 | N/A | Downgrades | 2 years ago |
Medicenna Therapeutics CorpMDNAF | 9 | Buy | $2.50 | N/A | Reiterates | 3 years ago |
Surface Oncology IncSURF | 6 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Alaunos Therapeutics IncTCRT | 3 | Buy | $225.00 | N/A | Upgrades | 3 years ago |
Surgalign Holdings IncSRGAQ | 3 | Buy | $3.50 | N/A | Reiterates | 3 years ago |
Codexis IncCDXS | 9 | Buy | $9.00 | N/A | Maintains | 3 years ago |
Lava Therapeutics NvLVTX | 1 | Buy | $9.00 | N/A | Reiterates | 3 years ago |
Celularity IncCELU | 2 | Buy | $25.00 | N/A | Maintains | 3 years ago |
Poseida Therapeutics IncPSTX | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Adagene IncADAG | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Oncorus IncONCR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cellectar Biosciences IncCLRB | 1 | Buy | $120.00 | N/A | Maintains | 4 years ago |
Aveo Pharmaceuticals IncAVEO | 4 | Hold | $15.00 | N/A | Downgrades | 4 years ago |
Calithera Biosciences IncCALA | 2 | Buy | $8.00 | N/A | Upgrades | 4 years ago |
Cervomed IncCRVO | 3 | Buy | $9.50 | N/A | Upgrades | 4 years ago |
Bioatla IncBCAB | 2 | Buy | $1,000.00 | N/A | Maintains | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Notable Labs LtdNTBLQ | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Pulse Biosciences IncPLSE | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Hookipa Pharma IncHOOK | 5 | Buy | $80.00 | N/A | Maintains | 4 years ago |
Trillium Therapeutics IncTRIL1 | 3 | Hold | $18.50 | N/A | Downgrades | 5 years ago |
Carisma Therapeutics IncCARM | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $6.00 | N/A | Maintains | 5 years ago |
Kindred Biosciences IncKIN | 3 | Hold | $9.25 | N/A | Downgrades | 5 years ago |
Perspective Therapeutics IncCATX | 2 | Buy | $2.10 | N/A | Maintains | 5 years ago |
Inmune Bio IncINMB | 2 | Buy | $20.00 | N/A | Maintains | 6 years ago |
Intelgenx Technologies CorpIGXT | 1 | Buy | $0.50 | N/A | Reiterates | 6 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $35.00 | N/A | Maintains | 6 years ago |
Verastem IncVSTM | 1 | Buy | $33.00 | N/A | Maintains | 6 years ago |
Alphatec Holdings IncATEC | 2 | Buy | $9.50 | N/A | Reiterates | 6 years ago |
Redhill Biopharma LtdRDHL | 1 | Buy | $14,000.00 | N/A | Reiterates | 6 years ago |
Forty Seven IncFTSV | 1 | Hold | $95.50 | N/A | Downgrades | 6 years ago |
Correvio Pharma CorpCORV | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Buy | $7,200.00 | N/A | Maintains | 8 years ago |
Aratana Therapeutics IncPETX | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 8 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 9 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Buy | $14.00 | N/A | Assumes | 9 years ago |
Seaspine Holdings CorpSPNE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.